clinical depression

Alto Neuroscience’s depression drug trial fails at phase 2
Biopharma Reporter
Thu, 10/24/24 - 10:50 am
Alto Neuroscience
clinical trials
clinical depression
ALTO-100
FDA rules Otsuka marketing claim overstates Rexulti efficacy, threatening cornerstone of huge TV push
Fierce Pharma
Tue, 11/14/23 - 11:19 am
Otsuka
FDA
Rexulti
pharma marketing
clinical depression
Axsome's depression drug enters competitive market after U.S. approval
Reuters
Fri, 08/19/22 - 10:37 am
Axsome Therapeutics
clinical depression
FDA
Auvelity
Chasing Sage, PureTech’s oral depression drug clears early bioavailability test
Fierce Pharma
Tue, 06/14/22 - 09:09 pm
PureTech Health
SAGE Therapeutics
allopregnanolone
clinical trials
clinical depression
Biogen, Sage plot 2022 filing for zuranolone approval, furthering turnaround of depression drug
Fierce Biotech
Tue, 10/19/21 - 11:54 am
Biogen
SAGE Therapeutics
zuranolone
FDA
clinical depression
J&J scores Spravato trial win in high-risk depression. Will doctors and payers buy in?
Fierce Pharma
Tue, 09/10/19 - 11:31 am
JNJ
clinical depression
high-risk depression
Spravato
physicians
payers
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
J&J builds case for ketamine-based depression drug
Biopharma Dive
Wed, 01/3/18 - 10:07 am
JNJ
esketamine
ketamine
clinical depression
Allergan, Gedeon Richter plan depression submission
BioPharma Dive
Tue, 12/19/17 - 10:21 pm
Allergan
Gedeon
clinical depression
Vraylar
acute bipolar depression
Don't give up on tough-to-treat depression, Janssen R&D says in new video push
Fierce Pharma
Mon, 10/16/17 - 11:52 am
clinical depression
Janssen
R&D
JNJ
J&J beefs up neuro pipeline, bags a new depression drug from Cerecor in $45M deal
Endpoints
Mon, 08/14/17 - 10:33 am
JNJ
Cerecor
CERC-501
clinical depression
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Endpoints
Tue, 07/25/17 - 09:39 am
Neuralstem
clinical trials
NSI-189
clinical depression
Allergan To Test Botox For Depression Despite Mixed Results
Forbes
Thu, 04/6/17 - 10:04 am
Allergan
Botox
clinical depression
clinical trials
Tech-focused Takeda pilots Apple Watch trial to collect depression data
Fierce Pharma
Wed, 03/1/17 - 09:07 pm
Takeda
Apple
Apple Watch
clinical depression
wearables
Allergan eyes depression as blockbuster Botox's next big stage
Fierce Pharma
Mon, 12/19/16 - 11:44 am
Allergan
Botox
clinical depression
Pfizer creates app for patients with depression
Medical Marketing and Media
Fri, 12/16/16 - 09:44 am
Pfizer
clinical depression
apps
mobile medical apps
Pristiq
Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater
Endpoints
Wed, 11/30/16 - 09:58 am
Cerecor
clinical depression
clinical trials
CERC-501
Eli Lilly
Alkermes
A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA
Forbes
Thu, 10/20/16 - 08:13 pm
biotech
FDA
Alkermes
clinical depression
ALKS 5461
antidepressants
Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression
Forbes
Tue, 02/9/16 - 09:28 am
Alkermes
Richard Pops
ALKS 5461
clinical depression
Alkermes slammed as top depression drug fails two PhIIIs
Fierce Biotech
Thu, 01/21/16 - 05:42 pm
Alkermes
ALKS-5461
clinical depression
clinical trials

Pages